2020-08-20 |
2020-08-20 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
|
300,000
-3.4%
11.46
USD 3,438,000
|
300,000
-3.4%
|
11.46
|
USD 3,438,000
|
|
2020-08-20 |
2020-08-19 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
|
300,000
-3.3%
12.00
USD 3,600,000
|
300,000
-3.3%
|
12.00
|
USD 3,600,000
|
|
2020-08-20 |
2020-08-18 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
|
300,000
-3.2%
12.12
USD 3,636,000
|
300,000
-3.2%
|
12.12
|
USD 3,636,000
|
|
2020-08-07 |
2020-08-07 |
S
Sale
|
Roberts Colin
See Remarks
Officer
|
30,000
-9.7%
11.14
USD 334,200
|
30,000
-9.7%
|
11.14
|
USD 334,200
|
|
2020-08-07 |
2020-08-07 |
S
Sale
|
Dalton Ryan
See Remarks
Officer
|
60,000
-12.6%
11.14
USD 668,400
|
60,000
-12.6%
|
11.14
|
USD 668,400
|
|
2020-03-09 |
2020-03-06 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
2,000
+1.4%
11.25
USD 22,500
|
2,000
+1.4%
|
11.25
|
USD 22,500
|
|
2020-03-09 |
2020-03-06 |
B
Purchase
|
Brokmeyer Ron
Non-Executive Director
|
1,800
+6.2%
11.15
USD 20,070
|
1,800
+6.2%
|
11.15
|
USD 20,070
|
|
2020-03-09 |
2020-03-06 |
B
Purchase
|
Windlinger Jerry
Non-Executive Director
|
1,618
+4.8%
11.32
USD 18,316
|
1,618
+4.8%
|
11.32
|
USD 18,316
|
|
2020-03-09 |
2020-03-05 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
1,000
+0.7%
12.60
USD 12,600
|
1,000
+0.7%
|
12.60
|
USD 12,600
|
|
2020-03-04 |
2020-03-03 |
B
Purchase
|
Brokmeyer Ron
Non-Executive Director
|
1,000
+3.5%
12.70
USD 12,700
|
1,000
+3.5%
|
12.70
|
USD 12,700
|
|
2020-02-28 |
2020-02-27 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
10,000
+7.6%
13.10
USD 131,000
|
10,000
+7.6%
|
13.10
|
USD 131,000
|
|
2019-12-06 |
2019-12-06 |
S
Sale
|
Roberts Colin
See Remarks
Officer
|
10,000
-3.7%
16.36
USD 163,600
|
10,000
-3.7%
|
16.36
|
USD 163,600
|
|
2019-12-06 |
2019-12-05 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
316,700
-3.6%
15.63
USD 4,950,021
|
316,700
-3.6%
|
15.63
|
USD 4,950,021
|
|
2019-12-02 |
2019-11-29 |
B
Purchase
|
Brokmeyer Ron
Non-Executive Director
|
5,000
+28.2%
14.95
USD 74,750
|
5,000
+28.2%
|
14.95
|
USD 74,750
|
|
2019-06-06 |
2019-06-05 |
B
Purchase
|
Windlinger Jerry
|
1,985
+6.3%
17.50
USD 34,738
|
1,985
+6.3%
|
17.50
|
USD 34,738
|
|
2019-05-22 |
2019-05-20 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
100,000
-1.1%
20.24
USD 2,024,210
|
100,000
-1.1%
|
20.24
|
USD 2,024,210
|
|
2019-04-12 |
2019-04-12 |
S
Sale
|
Roberts Colin
See Remarks
|
3,000
-1.1%
20.00
USD 60,000
|
3,000
-1.1%
|
20.00
|
USD 60,000
|
|
2019-03-06 |
2019-03-05 |
S
Sale
|
Roberts Colin
See Remarks
|
3,500
-1.3%
18.73
USD 65,559
|
3,500
-1.3%
|
18.73
|
USD 65,559
|
|
2019-03-01 |
2019-03-01 |
S
Sale
|
Hinson Mike
See Remarks
Officer
|
41,727
-9.5%
18.43
USD 769,029
|
41,727
-9.5%
|
18.43
|
USD 769,029
|
|
2019-03-01 |
2019-02-28 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
725,000
-7.5%
18.25
USD 13,233,208
|
725,000
-7.5%
|
18.25
|
USD 13,233,208
|
|
2018-12-06 |
2018-12-04 |
B
Purchase
|
Windlinger Jerry
Non-Executive Director
|
3,193
+16.1%
19.94
USD 63,668
|
3,193
+16.1%
|
19.94
|
USD 63,668
|
|
2018-12-04 |
2018-12-04 |
B
Purchase
|
Brokmeyer Ron
Non-Executive Director
|
1,000
+6.0%
19.99
USD 19,990
|
1,000
+6.0%
|
19.99
|
USD 19,990
|
|
2018-12-03 |
2018-11-30 |
B
Purchase
|
Brokmeyer Ron
Non-Executive Director
|
3,000
+21.9%
20.30
USD 60,900
|
3,000
+21.9%
|
20.30
|
USD 60,900
|
|
2018-12-03 |
2018-11-30 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
1,000
+0.8%
20.00
USD 20,000
|
1,000
+0.8%
|
20.00
|
USD 20,000
|
|
2018-11-27 |
2018-11-27 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
5,000
+4.3%
21.10
USD 105,499
|
5,000
+4.3%
|
21.10
|
USD 105,499
|
|
2018-09-05 |
2018-09-04 |
B
Purchase
|
Desai Hemang
Non-Executive Director
|
1,000
+50.0%
27.32
USD 27,320
|
1,000
+50.0%
|
27.32
|
USD 27,320
|
|
2018-08-30 |
2018-08-28 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
2,500,000
-21.7%
28.15
USD 70,375,000
|
2,500,000
-21.7%
|
28.15
|
USD 70,375,000
|
|
2018-08-24 |
2018-08-24 |
S
Sale
|
Hinson Mike
See Remarks
Officer
|
13,328
-3.2%
28.75
USD 383,180
|
13,328
-3.2%
|
28.75
|
USD 383,180
|
|
2018-08-10 |
2018-08-10 |
S
Sale
|
Hinson Mike
See Remarks
Officer
|
250,000
-37.7%
30.24
USD 7,560,000
|
250,000
-37.7%
|
30.24
|
USD 7,560,000
|
|
2018-06-29 |
2018-06-27 |
PS
Planned sale
|
Roberts Colin
See Remarks
Officer
|
10,000
-4.3%
30.21
USD 302,100
|
10,000
-4.3%
|
30.21
|
USD 302,100
|
|
2018-05-17 |
2018-05-15 |
PS
Planned sale
|
Roberts Colin
See Remarks
Officer
|
10,000
-3.9%
31.59
USD 315,900
|
10,000
-3.9%
|
31.59
|
USD 315,900
|
|
2018-05-10 |
2018-05-08 |
S
Sale
|
Hinson Mike
See Remarks
Officer
|
41,681
-9.0%
31.95
USD 1,331,708
|
41,681
-9.0%
|
31.95
|
USD 1,331,708
|
|
2018-05-10 |
2018-05-08 |
S
Sale
|
Gallagher Matthew
See Remarks
Executive Director
|
142,971
-19.1%
31.77
USD 4,542,189
|
142,971
-19.1%
|
31.77
|
USD 4,542,189
|
|
2018-05-10 |
2018-05-08 |
S
Sale
|
Dalton Ryan
See Remarks
Officer
|
60,742
-15.4%
31.77
USD 1,929,773
|
60,742
-15.4%
|
31.77
|
USD 1,929,773
|
|
2018-04-04 |
2018-04-02 |
PS
Planned sale
|
Roberts Colin
See Remarks
Officer
|
7,500
-2.9%
28.29
USD 212,175
|
7,500
-2.9%
|
28.29
|
USD 212,175
|
|
2018-03-02 |
2018-03-01 |
B
Purchase
|
Windlinger Jerry
|
3,000
+26.5%
25.48
USD 76,440
|
3,000
+26.5%
|
25.48
|
USD 76,440
|
|
2018-03-01 |
2018-03-01 |
B
Purchase
|
Smith David Henry
|
2,000
+5.5%
25.35
USD 50,700
|
2,000
+5.5%
|
25.35
|
USD 50,700
|
|
2018-02-28 |
2018-02-28 |
B
Purchase
|
Brokmeyer Ron
Non-Executive Director
|
2,000
+17.1%
25.66
USD 51,320
|
2,000
+17.1%
|
25.66
|
USD 51,320
|
|
2018-02-28 |
2018-02-27 |
S
Sale
|
Roberts Colin
See Remarks
Officer
|
10,000
-3.7%
26.14
USD 261,400
|
10,000
-3.7%
|
26.14
|
USD 261,400
|
|
2018-02-28 |
2018-02-27 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
10,000
+9.8%
25.99
USD 259,900
|
10,000
+9.8%
|
25.99
|
USD 259,900
|
|
2018-02-26 |
2018-02-26 |
B
Purchase
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
189,500
+1.7%
26.34
USD 4,991,430
|
189,500
+1.7%
|
26.34
|
USD 4,991,430
|
|
2017-06-02 |
2017-06-01 |
S
Sale
|
Roberts Colin
See Remarks
|
3,400
-1.5%
30.00
USD 102,000
|
3,400
-1.5%
|
30.00
|
USD 102,000
|
|
2017-05-19 |
2017-05-17 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
1,600
+1.7%
31.65
USD 50,632
|
1,600
+1.7%
|
31.65
|
USD 50,632
|
|
2017-05-19 |
2017-05-17 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
1,900
+2.0%
31.65
USD 60,128
|
1,900
+2.0%
|
31.65
|
USD 60,128
|
|
2017-05-12 |
2017-05-11 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
837,500
-6.9%
31.45
USD 26,339,375
|
837,500
-6.9%
|
31.45
|
USD 26,339,375
|
|
2017-05-12 |
2017-05-10 |
S
Sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
850,000
-6.6%
31.40
USD 26,690,000
|
850,000
-6.6%
|
31.40
|
USD 26,690,000
|
|
2017-05-12 |
2017-05-10 |
S
Sale
|
Dalton Ryan
See Remarks
Officer
|
30,000
-8.3%
32.56
USD 976,800
|
30,000
-8.3%
|
32.56
|
USD 976,800
|
|
2017-05-02 |
2017-05-01 |
PS
Planned sale
|
Roberts Colin
See Remarks
Officer
|
3,000
-1.3%
29.56
USD 88,680
|
3,000
-1.3%
|
29.56
|
USD 88,680
|
|
2017-03-31 |
2017-03-31 |
PS
Planned sale
|
Roberts Colin
See Remarks
|
15,598
-6.2%
32.10
USD 500,696
|
15,598
-6.2%
|
32.10
|
USD 500,696
|
|
2017-03-02 |
2017-03-01 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
3,500
+3.9%
30.94
USD 108,290
|
3,500
+3.9%
|
30.94
|
USD 108,290
|
|
2017-03-02 |
2017-02-28 |
B
Purchase
|
Gallagher Matthew
See remarks
|
1,270
+0.2%
30.44
USD 38,659
|
1,270
+0.2%
|
30.44
|
USD 38,659
|
|
2017-03-02 |
2017-02-28 |
B
Purchase
|
Gallagher Matthew
See remarks
|
31,715
+5.0%
30.19
USD 957,476
|
31,715
+5.0%
|
30.19
|
USD 957,476
|
|
2017-03-02 |
2017-02-28 |
B
Purchase
|
Windlinger Jerry
|
3,000
+112.5%
30.35
USD 91,050
|
3,000
+112.5%
|
30.35
|
USD 91,050
|
|
2016-12-09 |
2016-12-07 |
PS
Planned sale
|
Hinson Mike
See Remarks
Officer
|
25,000
-5.6%
36.05
USD 901,250
|
25,000
-5.6%
|
36.05
|
USD 901,250
|
|
2016-11-23 |
2016-11-21 |
PS
Planned sale
|
Hinson Mike
See Remarks
Officer
|
25,000
-5.3%
36.18
USD 904,500
|
25,000
-5.3%
|
36.18
|
USD 904,500
|
|
2016-11-18 |
2016-11-18 |
S
Sale
|
Dalton Ryan
See Remarks
Officer
|
12,700
-5.1%
34.90
USD 443,230
|
12,700
-5.1%
|
34.90
|
USD 443,230
|
|
2016-11-18 |
2016-11-18 |
S
Sale
|
Roberts Colin
Vice President-General Counsel
Officer
|
5,000
-2.1%
34.92
USD 174,600
|
5,000
-2.1%
|
34.92
|
USD 174,600
|
|
2016-11-18 |
2016-11-17 |
B
Purchase
|
ALAMEDDINE A R
Non-Executive Director
|
8,000
+9.8%
34.75
USD 278,000
|
8,000
+9.8%
|
34.75
|
USD 278,000
|
|
2016-11-18 |
2016-11-17 |
S
Sale
|
Dalton Ryan
See Remarks
Officer
|
7,300
-2.9%
35.11
USD 256,303
|
7,300
-2.9%
|
35.11
|
USD 256,303
|
|
2016-11-17 |
2016-11-17 |
PS
Planned sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
28,676
-0.2%
34.66
USD 993,910
|
28,676
-0.2%
|
34.66
|
USD 993,910
|
|
2016-11-17 |
2016-11-17 |
PS
Planned sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
33,824
-0.3%
35.38
USD 1,196,693
|
33,824
-0.3%
|
35.38
|
USD 1,196,693
|
|
2016-11-17 |
2016-11-16 |
PS
Planned sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
113,806
-0.9%
34.73
USD 3,952,482
|
113,806
-0.9%
|
34.73
|
USD 3,952,482
|
|
2016-11-17 |
2016-11-15 |
PS
Planned sale
|
Sheffield Bryan
See Remarks
Executive Director
Large shareholder
|
136,194
-1.0%
34.95
USD 4,759,980
|
136,194
-1.0%
|
34.95
|
USD 4,759,980
|
|
2016-11-09 |
2016-11-07 |
PS
Planned sale
|
Hinson Mike
See Remarks
Officer
|
25,000
-5.0%
34.05
USD 851,250
|
25,000
-5.0%
|
34.05
|
USD 851,250
|
|
2016-10-24 |
2016-10-21 |
PS
Planned sale
|
Hinson Mike
See Remarks
Officer
|
25,000
-4.8%
|